As healthcare professionals, it is imperative to stay informed about diseases that significantly impact our patients' lives, such as Parkinson's Disease (PD). This neurodegenerative disorder affects millions globally and presents unique challenges due to its progressive nature and diverse symptomatology.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to an imbalance in dopamine and acetylcholine. This imbalance results in motor and non-motor symptoms. The presence of Lewy bodies, protein aggregates mainly composed of alpha-synuclein, is another hallmark of PD.
PD typically manifests with motor symptoms such as tremors, bradykinesia, rigidity, and postural instability. However, non-motor symptoms like autonomic dysfunction, cognitive impairment, and mood disorders often precede motor symptoms and impact the quality of life significantly.
Diagnosis of PD is primarily clinical, based on history and physical examination. There are no definitive diagnostic tests, but neuroimaging can aid in differential diagnosis. Management involves pharmacological treatment, primarily levodopa, and non-pharmacological interventions like physiotherapy and occupational therapy.
Research is ongoing to understand the genetic and environmental factors contributing to PD, and to develop disease-modifying therapies. Deep Brain Stimulation (DBS) and stem cell therapy are promising advancements in the field.
Understanding Parkinson's Disease is crucial for healthcare professionals to provide comprehensive care. Staying updated with the latest research and advancements can help improve the quality of life for our patients and pave the way for future breakthroughs in management strategies.
1.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
2.
Nodal Response After Chemo Helps Tailor Breast Radiotherapy
3.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
4.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
5.
Common intracellular toxin could help fight leukemia
1.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
2.
Clonal Hematopoiesis and Thrombotic Risk Beyond Cancer: A Comprehensive Review for Clinicians
3.
Unlocking The Causes And Risk Factors Of Breast Cancer
4.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
5.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Thromboprophylaxis In Medical Settings
2.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
3.
How Multidisciplinary Teams Support Modern Cancer Care
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation